BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17363494)

  • 1. Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells.
    Ahmad KA; Harris NH; Johnson AD; Lindvall HC; Wang G; Ahmed K
    Mol Cancer Ther; 2007 Mar; 6(3):1006-12. PubMed ID: 17363494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
    Wang G; Ahmad KA; Ahmed K
    Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
    Ahmad KA; Wang G; Ahmed K
    Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S; Hussain T; Mukhtar H
    Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro.
    Alex AF; Spitznas M; Tittel AP; Kurts C; Eter N
    Curr Eye Res; 2010 Nov; 35(11):1021-33. PubMed ID: 20958191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
    Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
    Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK2 signaling in androgen-dependent and -independent prostate cancer.
    Wang G; Ahmad KA; Unger G; Slaton JW; Ahmed K
    J Cell Biochem; 2006 Oct; 99(2):382-91. PubMed ID: 16598768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
    Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
    Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma.
    Baatout S; Derradji H; Jacquet P; Mergeay M
    Int J Mol Med; 2005 Feb; 15(2):337-52. PubMed ID: 15647852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.
    Shankar S; Siddiqui I; Srivastava RK
    Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
    Gill C; Walsh SE; Morrissey C; Fitzpatrick JM; Watson RW
    Prostate; 2007 Nov; 67(15):1641-53. PubMed ID: 17823925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
    Hsieh TC; Wu JM
    Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of resveratrol and other wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells.
    Ferruelo A; Romero I; Cabrera PM; Arance I; Andrés G; Angulo JC
    Actas Urol Esp; 2014; 38(6):397-404. PubMed ID: 24726691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth
    Amin ARMR; Wang D; Nannapaneni S; Lamichhane R; Chen ZG; Shin DM
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33864659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
    Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
    Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.